| Name | Title | Contact Details |
|---|---|---|
Peter Wang |
Chief Technology Officer | Profile |
Wish Recovery is a luxury rehab and detox facility in Los Angeles that offers personalized and comprehensive care for individuals struggling with alcohol and drug addiction.
Raytel Medical Corporation is a Windsor, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tympany, LLC is a Spring, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Grembowiec and Associates Inc is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.